Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2137756

Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Description:
Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Europe Neurology Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Neurology Devices market..
- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Stryker Corporation, Corporation, B. Braun Melsungen AG, Accuray Incorporated, Cadwell Laboratories, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
 
Contents:
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Neurology Devices in Europe
3.1 Neurology Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
3.2 Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Neurology Devices, Europe, Company share (2010-2011)
4 Neurology Devices In Germany
4.1 Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Neurology Devices, Germany, Distribution Share (2010-2011)
4.2.1 CSF Management, Germany, Distribution Share (2010-2011)
4.2.2 Interventional Neurology, Germany, Distribution Share (2010-2011)
4.2.3 Neurological Diagnostic Equipment, Germany, Distribution Share (2010-2011)
4.2.4 Neurostimulation Devices, Germany, Distribution Share (2010-2011)
4.2.5 Neurosurgical Products, Germany, Distribution Share (2010-2011)
4.2.6 Radiosurgery, Germany, Distribution Share (2010-2011)
4.3 Neurology Devices, Germany, Company Share (2010-2011)
4.3.1 Neurology Devices, Germany, Company Share (2010-2011)
4.3.2 CSF Management, Germany, Company Share (2010-2011)
4.3.3 Interventional Neurology, Germany, Company Share (2010-2011)
4.3.4 Neurological Diagnostic Equipment, Germany, Company Share (2010-2011)
4.3.5 Neurostimulation Devices, Germany, Company Share (2010-2011)
4.3.6 Neurosurgical Products, Germany, Company Share (2010-2011)
4.3.7 Radiosurgery, Germany, Company Share (2010-2011)
5 Neurology Devices In France
5.1 Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Neurology Devices, France, Distribution Share (2010-2011)
5.2.1 CSF Management, France, Distribution Share (2010-2011)
5.2.2 Interventional Neurology, France, Distribution Share (2010-2011)
5.2.3 Neurological Diagnostic Equipment, France, Distribution Share (2010-2011)
5.2.4 Neurostimulation Devices, France, Distribution Share (2010-2011)
5.2.5 Neurosurgical Products, France, Distribution Share (2010-2011)
5.2.6 Radiosurgery, France, Distribution Share (2010-2011)
5.3 Neurology Devices, France, Company Share (2010-2011)
5.3.1 Neurology Devices, France, Company Share (2010-2011)
5.3.2 CSF Management, France, Company Share (2010-2011)
5.3.3 Interventional Neurology, France, Company Share (2010-2011)
5.3.4 Neurological Diagnostic Equipment, France, Company Share (2010-2011)
5.3.5 Neurostimulation Devices, France, Company Share (2010-2011)
5.3.6 Neurosurgical Products, France, Company Share (2010-2011)
5.4 Radiosurgery, France, Company Share (2010-2011)
6 Neurology Devices In United Kingdom
6.1 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
6.2 Neurology Devices, United Kingdom, Distribution Share (2010-2011)
6.2.1 CSF Management, United Kingdom, Distribution Share (2010-2011)
6.2.2 Interventional Neurology, United Kingdom, Distribution Share (2010-2011)
6.2.3 Neurological Diagnostic Equipment, United Kingdom, Distribution Share (2010-2011)
6.2.4 Neurostimulation Devices, United Kingdom, Distribution Share (2010-2011)
6.2.5 Neurosurgical Products, United Kingdom, Distribution Share (2010-2011)
6.2.6 Radiosurgery, United Kingdom, Distribution Share (2010-2011)
6.3 Neurology Devices, United Kingdom, Company Share (2010-2011)
6.3.1 Neurology Devices, United Kingdom, Company Share (2010-2011)
6.3.2 CSF Management, United Kingdom, Company Share (2010-2011)
6.3.3 Interventional Neurology, United Kingdom, Company Share (2010-2011)
6.3.4 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011)
6.3.5 Neurostimulation Devices, United Kingdom, Company Share (2010-2011)
6.3.6 Neurosurgical Products, United Kingdom, Company Share (2010-2011)
6.3.7 Radiosurgery, United Kingdom, Company Share (2010-2011)
7 Neurology Devices In Italy
7.1 Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018
7.2 Neurology Devices, Italy, Distribution Share (2010-2011)
7.2.1 CSF Management, Italy, Distribution Share (2010-2011)
7.2.2 Interventional Neurology, Italy, Distribution Share (2010-2011)
7.2.3 Neurological Diagnostic Equipment, Italy, Distribution Share (2010-2011)
7.2.4 Neurostimulation Devices, Italy, Distribution Share (2010-2011)
7.2.5 Neurosurgical Products, Italy, Distribution Share (2010-2011)
7.2.6 Radiosurgery, Italy, Distribution Share (2010-2011)
7.3 Neurology Devices, Italy, Company Share (2010-2011)
7.3.1 Neurology Devices, Italy, Company Share (2010-2011)
7.3.2 CSF Management, Italy, Company Share (2010-2011)
7.3.3 Interventional Neurology, Italy, Company Share (2010-2011)
7.3.4 Neurological Diagnostic Equipment, Italy, Company Share (2010-2011)
7.3.5 Neurostimulation Devices, Italy, Company Share (2010-2011)
7.3.6 Neurosurgical Products, Italy, Company Share (2010-2011)
7.3.7 Radiosurgery, Italy, Company Share (2010-2011)
8 Neurology Devices In Spain
8.1 Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018
8.2 Neurology Devices, Spain, Distribution Share (2010-2011)
8.2.1 CSF Management, Spain, Distribution Share (2010-2011)
8.2.2 Interventional Neurology, Spain, Distribution Share (2010-2011)
8.2.3 Neurological Diagnostic Equipment, Spain, Distribution Share (2010-2011)
8.2.4 Neurostimulation Devices, Spain, Distribution Share (2010-2011)
8.2.5 Neurosurgical Products, Spain, Distribution Share (2010-2011)
8.2.6 Radiosurgery, Spain, Distribution Share (2010-2011)
8.3 Neurology Devices, Spain, Company Share (2010-2011)
8.3.1 Neurology Devices, Spain, Company Share (2010-2011)
8.3.2 CSF Management, Spain, Company Share (2010-2011)
8.3.3 Interventional Neurology, Spain, Company Share (2010-2011)
8.3.4 Neurological Diagnostic Equipment, Spain, Company Share (2010-2011)
8.3.5 Neurostimulation Devices, Spain, Company Share (2010-2011)
8.3.6 Neurosurgical Products, Spain, Company Share (2010-2011)
8.3.7 Radiosurgery, Spain, Company Share (2010-2011)
9 Overview of Key Companies in Europe Neurology Devices Market
9.1 Medtronic, Inc.
9.1.1 Company Overview
9.1.2 Share in the Europe Neurology Devices Market
9.2 St. Jude Medical, Inc.
9.2.1 Company Overview
9.2.2 Share in the Europe Neurology Devices Market
9.3 Stryker Corporation
9.3.1 Company Overview
9.3.2 Share in the Europe Neurology Devices Market
9.4 Accuray Incorporated
9.4.1 Company Overview
9.4.2 Share in the Europe Neurology Devices Market
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Share in the Europe Neurology Devices Market
9.6 DePuy, Inc.
9.6.1 Company Overview
9.6.2 Share in the Europe Neurology Devices Market
9.7 Cadwell Laboratories, Inc.
9.7.1 Company Overview
9.8 Covidien plc
9.8.1 Company Overview
9.9 Terumo Corporation
9.9.1 Company Overview
9.10 Cyberonics, Inc.
9.10.1 Company Overview
9.11 Integra LifeSciences Holdings Corporation
9.11.1 Company Overview
9.12 CareFusion Corporation
9.12.1 Company Overview
9.13 Christoph Miethke GmbH & Co. KG
9.13.1 Company Overview
9.14 Natus Medical Incorporated
9.14.1 Company Overview
9.15 Micromed S.p.A
9.15.1 Company Overview
9.16 Boston Scientific Corporation
9.16.1 Company Overview
9.17 Nihon Kohden Corporation
9.17.1 Company Overview
9.18 Elekta AB
9.18.1 Company Overview
9.19 Sophysa S.A.
9.19.1 Company Overview
9.20 KARL STORZ GmbH & Co. KG
9.20.1 Company Overview
10 Neurology Devices Market Pipeline Products
11 Financial Deals Landscape
11.1 Acquisition
11.1.1 Elekta Completes Acquisition Of Nucletron For $523 Million
11.2 Partnerships
11.2.1 Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center
11.2.2 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix
12 Recent Developments
12.1 Strategy And Business Planning
12.1.1 Feb 09, 2012: Zynex Forms European Subsidiary
12.1.2 Dec 19, 2011: Medical Centers Worldwide Adopt Both Accuray's CyberKnife And TomoTherapy Systems
12.1.3 Oct 27, 2011: Ambu Announces Organizational Re-Structuring As Part Of Strategy
12.1.4 Oct 13, 2011: Unisense Establishes US Headquarter
12.2 Research And Development
12.2.1 Mar 21, 2012: Index Ventures Launches New €150m Life Sciences Fund With Investments From GSK And Janssen
12.2.2 Nov 08, 2011: Bright Light Into Ear Canal Treats Seasonal Depression Effectively In Two Clinical Trials Presented By Valkee And University of Oulu
12.2.3 Aug 11, 2011: Valkee And University of Oulu Presents New Findings On Human Brain’s Photosensitivity At Scandinavian Physiology Society Annual Meeting 2011
12.3 Legal and Regulatory
12.3.1 Sep 26, 2011: Occlutech CEO Wins Patent Lawsuit By St Jude-AGA Medical
12.4 Government and Public Interest
12.4.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield
12.4.2 Feb 18, 2012: New EEG Shows How Brain Tracts Are Formed: Study
12.4.3 Jan 27, 2012: Elekta Demonstrates Comprehensive Range Of Cancer Management Solutions At 2012 Arab Health Congress And Exhibition
12.4.4 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise
12.4.5 Dec 15, 2011: Finland Researchers Develops Decision Support Tool To Help Diagnose Alzheimer’s Disease
12.5 Product News
12.5.1 Sep 26, 2011: Elekta To Showcase Its Products At 2011 ASTRO Meeting In Florida
13 Appendix
13.1 Definitions of Markets Covered in the Report
13.1.1 Neurology Devices
13.2 Research Methodology
13.3 Secondary Research
13.4 Primary Research
13.5 Models
13.6 Forecasts
13.7 Expert Panels
13.8 GlobalData Consulting
13.9 Currency Conversion
13.10 Contact Us
13.11 Disclaimer

1.1 List of Tables
Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018
Table 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: Neurology Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011
Table 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Table 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: CSF Management, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Interventional Neurology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Neurological Diagnostic Equipment, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Neurostimulation Devices, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Neurosurgical Products, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Radiosurgery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Neurology Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 17: CSF Management, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Interventional Neurology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Neurological Diagnostic Equipment, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Neurostimulation Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Neurosurgical Products, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Radiosurgery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 23: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018
Table 24: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 25: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 26: CSF Management, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 27: Interventional Neurology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 28: Neurological Diagnostic Equipment, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Neurostimulation Devices, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Neurosurgical Products, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Radiosurgery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Neurology Devices, France, Company Share, USD Constant, (2010-2011)
Table 33: CSF Management, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Interventional Neurology, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Neurological Diagnostic Equipment, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Neurostimulation Devices, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Neurosurgical Products, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Radiosurgery, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
Table 40: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 41: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 42: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 43: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 44: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 45: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 46: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 47: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 49: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 53: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018
Table 56: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 57: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 58: CSF Management, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Interventional Neurology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Neurological Diagnostic Equipment, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 61: Neurostimulation Devices, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 62: Neurosurgical Products, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 63: Radiosurgery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 64: Neurology Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 65: CSF Management, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 66: Interventional Neurology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 67: Neurological Diagnostic Equipment, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 68: Neurostimulation Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 69: Neurosurgical Products, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 70: Radiosurgery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 71: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018
Table 72: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 73: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 74: CSF Management, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 75: Interventional Neurology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 76: Neurological Diagnostic Equipment, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 77: Neurostimulation Devices, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 78: Neurosurgical Products, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 79: Radiosurgery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 80: Neurology Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 81: CSF Management, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 82: Interventional Neurology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 83: Neurological Diagnostic Equipment, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 84: Neurostimulation Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 85: Neurosurgical Products, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 86: Radiosurgery, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 87: Neurology Devices Market Pipeline Products
Table 88: Elekta Completes Acquisition Of Nucletron For $523 Million
Table 89: Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center
Table 90: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix

1.2 List of Figures
Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018
Figure 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 6: Neurology Devices, Europe, Company share (%), 2011
Figure 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Figure 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: Neurology Devices, Germany, Company Share (%), 2011
Figure 11: CSF Management, Germany, Company Share (%), 2011
Figure 12: Interventional Neurology, Germany, Company Share (%), 2011
Figure 13: Neurological Diagnostic Equipment, Germany, Company Share (%), 2011
Figure 14: Neurostimulation Devices, Germany, Company Share (%), 2011
Figure 15: Neurosurgical Products, Germany, Company Share (%), 2011
Figure 16: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018
Figure 17: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 18: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 19: Neurology Devices, France, Company Share (%), 2011
Figure 20: CSF Management, France, Company Share (%), 2011
Figure 21: Interventional Neurology, France, Company Share (%), 2011
Figure 22: Neurological Diagnostic Equipment, France, Company Share (%), 2011
Figure 23: Neurostimulation Devices, France, Company Share (%), 2011
Figure 24: Neurosurgical Products, France, Company Share (%), 2011
Figure 25: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
Figure 26: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 27: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 28: Neurology Devices, United Kingdom, Company Share (%), 2011
Figure 29: CSF Management, United Kingdom, Company Share (%), 2011
Figure 30: Interventional Neurology, United Kingdom, Company Share (%), 2011
Figure 31: Neurological Diagnostic Equipment, United Kingdom, Company Share (%), 2011
Figure 32: Neurostimulation Devices, United Kingdom, Company Share (%), 2011
Figure 33: Neurosurgical Products, United Kingdom, Company Share (%), 2011
Figure 34: Radiosurgery, United Kingdom, Company Share (%), 2011
Figure 35: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018
Figure 36: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 37: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 38: Neurology Devices, Italy, Company Share (%), 2011
Figure 39: CSF Management, Italy, Company Share (%), 2011
Figure 40: Interventional Neurology, Italy, Company Share (%), 2011
Figure 41: Neurological Diagnostic Equipment, Italy, Company Share (%), 2011
Figure 42: Neurostimulation Devices, Italy, Company Share (%), 2011
Figure 43: Neurosurgical Products, Italy, Company Share (%), 2011
Figure 44: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018
Figure 45: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 46: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 47: Neurology Devices, Spain, Company Share (%), 2011
Figure 48: CSF Management, Spain, Company Share (%), 2011
Figure 49: Interventional Neurology, Spain, Company Share (%), 2011
Figure 50: Neurological Diagnostic Equipment, Spain, Company Share (%), 2011
Figure 51: Neurostimulation Devices, Spain, Company Share (%), 2011
Figure 52: Neurosurgical Products, Spain, Company Share (%), 2011
Figure 53: Medtronic, Inc., Company Share (%), Europe Neurology Devices Market, 2011
Figure 54: St. Jude Medical, Inc., Company Share (%), Europe Neurology Devices Market, 2011
Figure 55: Stryker Corporation, Company Share (%), Europe Neurology Devices Market, 2011
Figure 56: Accuray Incorporated, Company Share (%), Europe Neurology Devices Market, 2011
Figure 57: B. Braun Melsungen AG, Company Share (%), Europe Neurology Devices Market, 2011
Figure 58: DePuy, Inc., Company Share (%), Europe Neurology Devices Market, 2011
 
Companies Mentioned
Medtronic, Inc.
St. Jude Medical, Inc.
Stryker Corporation
Accuray Incorporated
B. Braun Melsungen AG
DePuy, Inc.
Cadwell Laboratories, Inc.
Covidien plc
Terumo Corporation
Cyberonics, Inc.
Integra LifeSciences Holdings Corporation
CareFusion Corporation
Christoph Miethke GmbH & Co. KG
Natus Medical Incorporated
Micromed S.p.A
Boston Scientific Corporation
Nihon Kohden Corporation
Elekta AB
Sophysa S.A.
KARL STORZ GmbH & Co. KG
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2137756

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Dec 27, 2014
1:01:09 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Web Address

http://www.researchandmarkets.com/reports/2137756

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 3,500
Electronic (PDF) - Site License USD 7,000
Electronic (PDF) - Enterprisewide USD 10,500

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Dec 27, 2014
1:01:09 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)